ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
18.20
+0.12 (0.66%)
At close: Jun 27, 2025, 4:00 PM
18.76
+0.56 (3.08%)
After-hours: Jun 27, 2025, 7:23 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.79 billion as of June 27, 2025. Its market cap has increased by 104.07% in one year.
Market Cap
1.79B
Enterprise Value
1.58B
1-Year Change
104.07%
Ranking
Category
Stock Price
$18.20
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.79B, an increase of 214.56%. That is a compound annual growth rate of 55.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 1.56B | 52.40% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.80B |
| Johnson & Johnson | 365.03B |
| AbbVie | 329.56B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.64B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.28B |
| AstraZeneca | 216.45B |